Effect modification of aortic atheroma on the prognostic value of heart rate in hypertension

Journal of Hypertension

Volumn 31, Issue 3, 2013, Pages 484-491

  Courand, Pierre Yves ^a,b,c   Milon, Hugues ^a,b,c   Gustin, Marie Paule ^b,c   Froment, Alain ^e   Bricca, Giampiero ^b,c   Lantelme, Pierre ^a,b,c,d  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c University Lyon 1   (France)

^d Service de cardiologie Hôpital Nord Ouest   (France)

^e NONE

Author keywords

Arterial stiffness; Cardiovascular death; Heart rate; Hypertension; Target organ damage

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIHYPERTENSIVE AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; AORTA ATHEROSCLEROSIS; AORTOGRAPHY; ARTICLE; BLOOD VESSEL INJURY; CARDIOVASCULAR MORTALITY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PALPATION; PRIORITY JOURNAL; PROGNOSIS; PULSE RATE; SINUS RHYTHM; SURVIVAL; AORTA; ATHEROSCLEROTIC PLAQUE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AORTA; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS;

EID: 84884197615     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835c44bb     Document Type: Article

References (35)

1. Lechat P, Hulot JS, Escolano S, Mallet S, Leizorovicz A, Werhlen-Grandjean M, et al., on behalf of the CIBIS II Investigators. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103:1428-1433. (Pubitemid 32220636)
2. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27:65-75. (Pubitemid 41785934)
3. Böhm M, Swedberg K, Komadja M, Borer JS, Ford I, Dubost-Brama A, et al. Heart rate as a risk factor in chronic heart failure (shift): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376:886-894.
4. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125:1148-1154. (Pubitemid 23117352)
5. Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A. Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001; 37:1256-1261. (Pubitemid 34163578)
6. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, et al., Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162:2313-2321. (Pubitemid 35332514)
7. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 1999; 33:44-52. (Pubitemid 29061840)
8. Wilhelmsen L, Berglung G, Elmfeldt D, Fitzsimons T, Holzgreve H, Hosie J, et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987; 5:561-572.
9. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al., ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895-906. (Pubitemid 41265663)
10. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353:611-616. (Pubitemid 29087980)
11. Kizer JR, Dahlöf B, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Hypertension 2005; 45:46-52. (Pubitemid 40066412)
12. MRC trial of treatment of mild hypertension: principal results. Medical research council working party. BMJ 1985; 291:97-104.
13. Bangalore S, Sawhney S, Messerli FH. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 2008; 52:1482-1489.
14. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26:967-974. (Pubitemid 40695027)
15. Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT, et al., CRUSADE investigators. The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J 2010; 31:552-560.
16. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. AMA Arch Ophthalmol 1953; 49:117-138.
17. Kagan A, Aurell E, Tibblin G. Signs in the fundus oculi and arterial hypertension: unconventional assessment and significance. Bull World Health Organ 1967; 36:231-241.
18. Pavillon G, Laurent F. Certification and classification of death's causes. BEH 2003; 30-31:134-138.
19. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113:1489-1494. (Pubitemid 17092823)
20. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Schoenberger JA. Heart rate as a prognostic factor for coronary artery disease and mortality findings in three Chicago Epidemiological Studies. Am J Epidemiol 1980; 112:736-749. (Pubitemid 11130662)
21. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R, on behalf of the BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial. Lancet 2008; 372:817-821.
22. Disegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, Behar S. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. J Clin Epidemiol 1995; 48:1197-1205.
23. Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, Pepine CJ. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 2008; 29:1327-1334. (Pubitemid 351768127)
24. Hansen TW, Thijs L, Boggia J, Li Y, Kikuya M, Björklund- Bodegård K, et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 2008; 52:229-235.
25. Van Zwieten PA. Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics. J Hypertens 1997; 15 (Suppl 1):S3-S8. (Pubitemid 27089313)
26. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, Hickson SS, on behalf of the Anglo-Cardiff Collaboration Trial Investigators. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 2009; 53:524-531.
27. Pannier B, Brunel P, el Aroussy W, Lacolley P, Safar ME. Pulse pressure and echocardiographic findings in essential hypertension. J Hypertens 1989; 7:127-132. (Pubitemid 19073988)
28. Gerdts E, Franklin S, Rieck A, Papademetriou V, Wachtell K, Nieminen M, et al. Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study). Blood Press 2009; 18:180-186.
29. Golomb RA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114:688-699. (Pubitemid 44252311)
30. Nabel EG, Selwyn AP, Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 1990; 81:850-859. (Pubitemid 20090381)
31. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104:1477-1482. (Pubitemid 32917338)
32. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive and treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207. (Pubitemid 34225821)
33. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
34. Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J Cardiol 2012; 109:685-692.
35. Poulter NR, Dobson JE, Sever PS, Dahlöf B, Wedel H, Campbell NRC, on behalf of the ASCOT Investigators. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). J Am Coll Cardiol 2009; 54:1154-1161.